Transient receptor potential canonical channels are essential for maintaining the function of human pulmonary endothelial cells in PAH.

Structural and functional pulmonary MRI measurements may predict future pulmonary exacerbations among individuals with cystic fibrosis.

Underlying causes of recurrent pneumonia in children have changed in the last decade, indicating a need for individualized diagnostic approaches.

More people than ever are entering medical school, and with the number of applicants increasing, it is harder to get in.

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk reduction.

For the fifth consecutive year, the number of American teenagers using drugs and alcohol remains at a historic low.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

Elexacaftor/tezacaftor/ivacaftor use is linked to long-term decreases in chronic respiratory therapies in patients with cystic fibrosis.

Individuals with a history of immune-mediated inflammatory diseases (IMIDs) may have a higher risk for sarcoidosis onset, a Japanese study found.

Nearly 3000 pounds of raw ground beef sold in six states is being recalled after testing found possible contamination with E coli O26.

The American Academy of Pediatrics is suing HHS over nearly $12 million in federal funding cuts that it says put children’s health programs at risk.